Results 31 to 40 of about 3,861 (173)

New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials. [PDF]

PLoS ONE, 2015
Sevelamer hydrochloride is used widely, but its impact upon cardiovascular calcification, cardiovascular mortality, all-cause mortality and hospitalization is not known.Primary outcome was cardiovascular calcification (coronary artery calcification ...
Caixia Wang, Xun Liu, Yongming Zhou, Shaomin Li, Yanbing Chen, Yanni Wang, Tanqi Lou   +6 more
doaj   +1 more source

Pre-treatment of Dairy and Breast Milk with Sevelamer Hydrochloride and Sevelamer Carbonate to Reduce Phosphate.

, 2013
Item does not contain fulltextIntroduction: Young children and infants with chronic kidney disease are at increased risk of hyperphosphatemia because of high intake of dairy products.
Willems, J.L., Monnens, L.A.H., Houkes, L.M., Raaijmakers, R., Schroder, C.H.   +4 more
core   +1 more source

Colitis Associated With Sevelamer Carbonate: A Case Report

Annals of Internal Medicine: Clinical Cases, 2023
Sevelamer carbonate is an anion-exchange, nonabsorbable resin that is commonly used to treat hyperphosphatemia in patients with advanced chronic kidney disease and end-stage renal disease.
Prajwol Pant, David LaBel, Nora Hernandez Garcilazo, Shailendra Sharma, Sumughda Rayamajhi   +4 more
doaj   +1 more source

Hemorrhagic Papilledema in a Patient With End‐Stage Renal Disease and Meningioma: A Case Report

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Anterior cranial fossa meningioma can present with a constellation of symptoms that pose a diagnostic challenge, especially in patients with significant comorbidities like end‐stage renal disease (ESRD). We report a case where the classic triad of visual loss, headache, and anosmia was initially complicated by the patient's renal background ...
Farid Shekarchian, Mahdi Rafiee, Ghodsieh Zamani, Saeedeh‐sadat Mirtooni, Yoones Moniri   +4 more
wiley   +1 more source

Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study

Cogent Medicine, 2016
Introduction: Lanthanum carbonate (LC) and sevelamer hydrochloride (SH) are non-calcium-based phosphate binders (NCPB), used to manage hyperphosphatemia in patients with chronic kidney disease.
Asrar Khan, Titi Chen, Anis Khan, Elaine Chan, Karen Byth, Jackson Tan, David Harris   +6 more
doaj   +1 more source

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Toxins, 2019
High serum levels of gut-derived uremic toxins, especially p-cresyl sulfate (pCS), indoxyl sulfate (IS) and indole acetic acid (IAA), have been linked to adverse outcomes in patients with chronic kidney disease (CKD).
Youssef Bennis, Yan Cluet, Dimitri Titeca-Beauport, Najeh El Esper, Pablo Ureña, Sandra Bodeau, Christian Combe, Bertrand Dussol, Denis Fouque, Gabriel Choukroun, Sophie Liabeuf   +10 more
doaj   +1 more source

Acute kidney injury in a dog after ingestion of homemade modelling dough containing cream of tartar (potassium bitartrate)

Veterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary A 16‐month‐old, male, neutered cocker spaniel developed gastrointestinal signs following ingestion of a homemade modelling dough containing cream of tartar. Blood biochemistry (29 hours post‐ingestion) showed elevated creatinine, urea and symmetric dimethylarginine (SDMA).
Fiona Adam, Nicola Bates
wiley   +1 more source

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?

Toxins, 2020
Gut microbial metabolism is not only an important source of uremic toxins but may also help to maintain the vitamin K stores of the host. We hypothesized that sevelamer therapy, a commonly used phosphate binder in patients with end-stage kidney disease ...
Lu Dai, Björn K. Meijers, Bert Bammens, Henriette de Loor, Leon J. Schurgers, Abdul Rashid Qureshi, Peter Stenvinkel, Pieter Evenepoel   +7 more
doaj   +1 more source

Sevelamer in a diabetologist's perspective:A phosphate-binding resin with glucose-lowering potential

, 2015
Sevelamer is a calcium-free and metal-free phosphate-binding oral drug used in the management of hyperphosphataemia in chronic kidney disease. Preclinical and clinical trials have shown glucose and lipid-lowering effects of sevelamer, thereby giving rise
Hansen, M., Sonne, D. P., Rohde, U., Brønden, A., Knop, Filip K., Vilsbøll, T.   +5 more
core   +1 more source

Management of Refractory and Difficult‐To‐Treat Inflammatory Bowel Disease: An Expert Opinion Review

JCC Plus, Volume 1, Issue 5, September 2026.
This expert opinion offers a practical framework for refractory and difficult‐to‐treat IBD: confirm inflammation objectively, distinguish pharmacologic from structural and functional disease, and then escalate. Across ten clinical questions, the evidence is often limited to case series, and the resulting statements are identified as expert opinion ...
Filiz Akyuz, Oguz Kagan Bakkaloglu, Nalan Gulsen Unal, Ismail Hakki Kalkan, Mehmet Arhan, Ibrahim Hatemi, Taylan Kav, Murat Toruner, Hale Akpinar, Ahmet Tezel, Aykut Ferhat Celik   +10 more
wiley   +1 more source